| Metric | შპს საქართველოს ფარმაცევტული კომპანია | სს ნიკორა |
|---|---|---|
| Growth | ||
| Revenue | ₾4.1m₾4.3m | ₾749.7m₾603.3m |
| Revenue growth | -3.8% | 24.3% |
| Profitability | ||
| EBITDA | ₾318k₾421k | ₾84.0m₾65.3m |
| EBITDA margin | 7.8%9.9% | 11.2%10.8% |
| Net profit | ₾318k₾232k | ₾30.8m-₾13.8m |
| Net margin | 7.8%5.5% | 4.1%-2.3% |
| Balance sheet | ||
| Total assets | ₾2.1m₾1.2m | ₾415.1m₾382.7m |
| Total equity | ₾1.0m₾703k | ₾58.8m₾39.7m |
| ROE | 31.2%33.0% | 52.4%-34.7% |